This is supported by findings indicating that peripheral αβ+ T lymphocytes of IBS patients, compared to healthy controls, expressed increased proportions of the activation molecule CD28 and decreased proportions of the chemokine receptor CCR5, after stimulation with pathogen-associated molecular patterns, [27]. The gene discussed is CCR5; the disease is irritable bowel syndrome.